Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 134Thoracic 3Lymphoid 3Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Lymphoma 309Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 223Lymphoma, Follicular 203Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 150Recurrence 130Burkitt Lymphoma 120Lymphoma, Mantle-Cell 115Leukemia, Myeloid, Acute 106Hodgkin Disease 102Leukemia 101Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 88Neoplasms 81Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 64Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 51Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 42Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 32Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Interventions

Vincristine 1Rituximab 1Prednisone 1Oxaliplatin 1Lenalidomide 1Gemcitabine 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumor × Lymphoid × Clear all
NCT04999384 2025-11-18

First in Human, Dose Escalation Study of AN4005

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Recruiting
31 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumor

NCT05279300 2025-08-11

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

CStone Pharmaceuticals

Phase 1 Recruiting
480 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumor

NCT05487170 2025-03-04

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Ranok Therapuetics Co. Ltd.

Phase 1/2 Recruiting
32 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡